Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program

Fertility and Sterility

Volumn 73, Issue 4, 2000, Pages 817-820

  Hsieh, Yao Yuan ^a   Tsai, Horng Der ^a   Chang, Chi Chen ^a   Chang, Chi Chia ^a   Lo, Hui Yu ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

GnRH a; Gonadotropin releasing hormone analog; Leuprolide acetate; Leuprolide acetate depot

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE;

ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; INFERTILITY; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; TAIWAN;

ADULT; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; OVULATION INDUCTION; PITUITARY GLAND; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034019567     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00608-1     Document Type: Article

References (15)

1. Hazout A., de Ziegler D., Cornel C., Fernandez H., Lelaidier C., Frydman R. Comparison of short 7 day and prolonged treatment with gonadotropin releasing hormone agonist desensitization for controlled ovarian hyperstimulation. Fertil Steril. 59:1993;596-600.
2. Testart J., Lefevre B., Gougeon A. Effects of gonadotrophin releasing hormone agonists (GnRHa) on follicle and oocyte quality. Hum Reprod. 8:1993;511-518.
3. Juha T., Outi H., Kaisa J., Hannu M., Ratsula K., Maija T., et al. Subccutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF a randomized comparative study . Hum Reprod. 8:1993;2052-2055.
4. Devreker F., Govaerts I., Bertrand E., Van den Bergh M., Gervy C., Englert Y. The long-acting gonadotropin-releasing hormone analogs impaired the implantation rate. Fertil Steril. 65:1996;122-126.
5. Tsai H.D., Chen C.M., Lo H.Y., Chang C.C. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization. Hum Reprod. 10:1995;2909-2912.
6. Rutherfor A.J., Subak-Sharpe R.J., Dawson K.J., Margara R.A., Franks S., Winston R.M.L. Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinizing hormone releasing hormone. Br Med J. 296:1988;1765-1768.
7. Samuel K.W., Sweall G., Soules M.R. Psychosocial stress as a cause of infertility. Fertil Steril. 59:1993;685-689.
8. Gianaroli L., Ferraretti A.P., Feliciani E., Tabanelli C., Magli C., Fertini D. Prospective randomized study of D-Trp-6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles. Hum Reprod. 9:1994;220-225.
9. Porcu E., Dal Prato L., Seracchioli R., Fabbri R., Longhi M., Flamigni C. Comparison between depot and standard release triptoreine in in vitro fertilization pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results . Fertil Steril. 62:1994;126-132.
10. Dhont M., Onghena A., Coetsier T., De Sutter P. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Hum Reprod. 10:1995;791-796.
11. Neuspiller F., Levy M., Remohi J., Ruiz A., Simon C., Pellicer A. The use of long- and short-acting forms of gonadotrophin-releasing hormone analogs in women undergoing oocyte donation. Hum Reprod. 13:1998;1148-1151.
12. Dada T., Salha O., Baillie H.S., Sharma V. A comparison of three gonadotrophin-releasing hormone analogs in an in-vitro fertilization programme a prospective randomized study . Hum Reprod. 14:1999;288-293.
13. Simon A., Behshushan Am Shushan A., Zajicek G., Dorembus D., Lewin A., Laufer N. A comparison between a standard and reduced dose of D-Trp-6 luteinizing hormone administered after pituitary suppression for in-vitro fertilization. Hum Reprod. 9:1994;1813-1817.
14. Juan B., Fernando G., Roser C. Pituitary ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot. Hum Reprod. 7:1992;1230-1234.
15. Herman A., Raziel A., Strassburger D., Soffer Y., Bukovsky I., Ron-El R. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone. Hum Reprod. 11:1996;1552-1557.